ELV
Elevance Health Inc
NYSE: ELV · HEALTHCARE · HEALTHCARE PLANS
$369.07
-0.76% today
Updated 2026-05-04
Market cap
$80.93B
P/E ratio
15.80
P/S ratio
0.40x
EPS (TTM)
$23.59
Dividend yield
1.82%
52W range
$269 – $415
Volume
2.0M
WallStSmart proprietary scores
56
out of 100
Grade: C+
Hold
Investment rating
4.0
Growth
C5.0
Quality
C+5.5
Profitability
C+8.0
Valuation
A3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →198 stocks currently score above 75
Price targets
Analyst target
$388.95
+5.39%
12-Month target
$291.36
-21.06%
Intrinsic (DCF)
$1,011.48
Margin of safety
+63.51%
3 Strong Buy11 Buy8 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $4.10B — positive
+ 63.51% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 2.62%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $156.59B | $171.34B | $176.81B | $199.13B | $200.42B | $194.8B |
| Net income | $5.89B | $5.99B | $5.98B | $5.66B | $1.76B | — |
| EPS | — | — | — | — | $23.59 | $26.15 |
| Free cash flow | $7.25B | $6.76B | $4.55B | $3.17B | $4.10B | — |
| Profit margin | 3.76% | 3.49% | 3.38% | 2.84% | 2.62% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-12 | SCHULMAN, AMY W | Sale | 26 | $287.50 |
| 2026-03-06 | KENDRICK, CHARLES MORGAN JR | Sale | 3,196 | $284.92 |
| 2026-03-05 | COLLIS, STEVEN H | Buy | 3,000 | $289.84 |
Peer comparison
Smart narrative
Elevance Health Inc trades at $369.07. representing a P/E of 15.80x trailing earnings. Our Smart Value Score of 56/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $200.42B. with profit margins at 2.62%. Our DCF model estimates intrinsic value at $1,011.48.
Frequently asked questions
What is Elevance Health Inc's stock price?
Elevance Health Inc (ELV) trades at $369.07.
Is Elevance Health Inc overvalued?
Smart Value Score 56/100 (Grade C+, Hold). DCF value $1,011.48.
What is the price target of Elevance Health Inc (ELV)?
The analyst target price is $388.95, representing +5.4% upside from the current price of $369.07.
What is the intrinsic value of Elevance Health Inc (ELV)?
Based on our DCF model, intrinsic value is $1,011.48, a +63.5% margin of safety versus $369.07.
What is the future stock price of ELV by 2030?
Our research-backed model estimates Elevance Health Inc could reach $13,466.15 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Elevance Health Inc's revenue?
TTM revenue is $200.42B.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryHEALTHCARE PLANS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.40x
ROE12.10%
Beta0.67
50D MA$312.16
200D MA$324.94
Shares out0.22B
Float0.22B
Short ratio—
Avg volume2.0M
Performance
1 week+2.74%
1 month+23.92%
3 months+10.05%
YTD+6.31%
1 year—
3 years—
5 years—